Konstantin Schlick

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

Lisa Pleyer, Sonja Burgstaller, Michael Girschikofsky et al. · Annals of Hematology · 2014 · 96 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients

Katharina Troppan, Konstantin Schlick, Alexander Deutsch et al. · British Journal of Cancer · 2014 · 76 citations · Full text

Medicine, Immunology, Oncology +15

Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival

Lisa Pleyer, Ulrich Germing, Wolfgang R. Sperr et al. · Leukemia Research · 2014 · 66 citations

Medicine, Pharmacology, Pharmacotherapy +8

Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis

Jakob M. Riedl, Florian Posch, Lena Horvath et al. · European Journal of Cancer · 2021 · 58 citations · Full text

Medicine, Oncology, Pharmacology +9

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group

Lisa Pleyer, Hartmut Döhner, Hervé Dombret et al. · International Journal of Molecular Sciences · 2017 · 51 citations · Full text

Medicine, Hematology, Pharmacology +12